These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 71272)

  • 1. Antigenic differences between primary methylcholanthrene-induced rat sarcomas and post-surgical recurrences.
    Pimm MV; Baldwin RW
    Int J Cancer; 1977 Jul; 20(1):37-43. PubMed ID: 71272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple antigenic specificities within primary 3-methylcholanthrene-induced rat sarcomas and metastases.
    Pimm MV; Embleton MJ; Baldwin RW
    Int J Cancer; 1980 May; 25(5):621-9. PubMed ID: 6154664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-reacting tumor associated transplantation antigen on primary 3-methylcholanthrene-induced BALB/c sarcomas.
    Coggin JH
    Mol Biother; 1989; 1(4):223-8. PubMed ID: 2818874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-reacting antigens in chemically induced sarcomas are fetal determinants.
    Parker GA; Rosenberg SA
    J Immunol; 1977 May; 118(5):1590-4. PubMed ID: 67142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy of a carcinogen-induced murine sarcoma with soluble tumor-specific transplantation antigens.
    Kahan BD; Tanaka T; Pellis NR
    J Natl Cancer Inst; 1980 Nov; 65(5):1001-4. PubMed ID: 6159495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MCA sarcomas induced in scid mice are more immunogenic than MCA sarcomas induced in congenic, immunocompetent mice.
    Engel AM; Svane IM; Rygaard J; Werdelin O
    Scand J Immunol; 1997 May; 45(5):463-70. PubMed ID: 9160088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of immunization with an allogeneic tumor on the growth of primary methylcholanthrene-induced sarcomas in rats.
    Usubuchi I; Kudo H; Kano M; Suga M
    Tohoku J Exp Med; 1976 May; 119(1):79-83. PubMed ID: 951705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serologic identification of multiple tumor-associated antigens on murine sarcomas.
    Parker GA; Rosenberg SA
    J Natl Cancer Inst; 1977 May; 58(5):1303-9. PubMed ID: 67211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of H-2 antigen and immunogenicity of methylcholanthrene-induced murine sarcomas.
    Pearson T; Sikora K; Lennox E
    Br J Cancer; 1978 Apr; 37(4):530-5. PubMed ID: 77161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological analysis of cell surface antigens on methylcholanthrene-induced mouse sarcomas with antisera produced against the tumors.
    Tanimoto M; Takahashi T; Nishizuka Y
    Gan; 1982 Apr; 73(2):184-92. PubMed ID: 6288499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common transplantation antigens on methylcholanthrene-induced murine sarcomas detected by three assays of tumor rejection.
    Leffell MS; Coggin JH
    Cancer Res; 1977 Nov; 37(11):4112-9. PubMed ID: 908044
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of cell-free tumour-associated antigen preparations on the development of immunity to chemically induced rat tumours.
    Embleton MJ
    Int J Cancer; 1976 Nov; 18(5):622-9. PubMed ID: 791870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour-related antigen specificities associated with 3-methylcholanthrene-treated rat embryo cells.
    Embleton MJ; Baldwin RW
    Int J Cancer; 1979 Jun; 23(6):840-5. PubMed ID: 89103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylcholanthrene-induced mouse sarcomas express individually distinct major histocompatibility complex class I-associated peptides recognized by specific CD8+ T-cell lines.
    Kono K; Petersson M; Ciupitu AM; Wen T; Klein G; Kiessling R
    Cancer Res; 1995 Dec; 55(23):5648-55. PubMed ID: 7585649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-mediated reactivity to antigens shared by Moloney-virus-induced lymphomas (LSTRA) and certain 3-methylcholanthrene-induced mouse sarcomas.
    Hellström I; Hellström KE; Zeidman L; Bernstein ID; Brown JP
    Int J Cancer; 1979 Apr; 23(4):555-64. PubMed ID: 86527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-derived autophagosome vaccine: induction of cross-protective immune responses against short-lived proteins through a p62-dependent mechanism.
    Twitty CG; Jensen SM; Hu HM; Fox BA
    Clin Cancer Res; 2011 Oct; 17(20):6467-81. PubMed ID: 21810919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapeutic effect of allogeneic tumor cells on the growth of autochthonous 3-methylcholanthrene-induced sarcomas in rats.
    Kudo H; Suga M; Ogasawara M; Sato T; Usubuchi I
    Tohoku J Exp Med; 1979 Apr; 127(4):353-8. PubMed ID: 442081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in tumor-specific antigen expression during passage in vitro and in vivo of newly derived methylcholanthrene-induced sarcomas of BALB/C mice.
    Law LW
    Int J Cancer; 1980 Feb; 25(2):251-9. PubMed ID: 6156130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity to chemically induced rat sarcomas: study of the specificity of cytotoxic cells.
    Goguel AF; Nauciel C
    Ann Immunol (Paris); 1979; 130C(5):621-34. PubMed ID: 316679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of cross-immunity on autotransplantation of methylcholanthrene-induced rat sarcomas.
    Usubuchi I; Kudo H; Sobajima Y; Sato T; Kakisaka Y
    Tohoku J Exp Med; 1973 Jun; 110(2):155-60. PubMed ID: 4729241
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.